| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 05/30/2002 | US20020065274 Methods of using novel compounds as neuro-protective agents |
| 05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
| 05/29/2002 | EP1209157A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds |
| 05/29/2002 | EP1209154A1 Preparation of monofluoroalkenes |
| 05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
| 05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
| 05/29/2002 | EP0786457B1 Azole derivatives |
| 05/29/2002 | DE10055811A1 Tetrakisfluoroalkylborat-Salze und deren Verwendung als Leitsalze Tetrakisfluoroalkylborate salts and their use as electrolyte salts |
| 05/29/2002 | DE10055219A1 Verfahren zur Herstellung von Dithiazolyldisulfiden A process for preparing Dithiazolyldisulfiden |
| 05/29/2002 | CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof |
| 05/29/2002 | CN1350787A Synergistic herbicidal composition and method |
| 05/29/2002 | CN1350786A Synergistic herbicidal composition and method |
| 05/29/2002 | CN1085663C Aromatic amino ethers as pain relieving agents |
| 05/28/2002 | US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease |
| 05/28/2002 | US6395730 Potassium channel inhibitors |
| 05/28/2002 | US6395367 Electroconductivity |
| 05/23/2002 | WO2002040459A1 Preparation of monofluoroalkenes |
| 05/23/2002 | WO2002040445A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002040444A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002040431A2 Compounds having fungicidal activity and processes to make and use same |
| 05/23/2002 | WO2002039976A1 Use of 2-oxothiazolidine 4-carboxylic acid derivatives as agents promoting skin peeling |
| 05/23/2002 | WO2002022612A8 Thiazolidine derivatives and its use as antifungal agent |
| 05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
| 05/23/2002 | WO2001073103A3 Preparation of epothilone intermediates |
| 05/23/2002 | US20020062030 Method for synthesizing epothilones and epothilone analogs |
| 05/23/2002 | US20020062028 Process for water soluble azole compounds |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | DE10055713A1 New diaryl-substituted azole compounds, useful in human or veterinary medicine as broad spectrum antifungal agents effective against fluconazole-resistant strains |
| 05/23/2002 | CA2428733A1 Compounds having fungicidal activity and processes to make and use same |
| 05/22/2002 | EP1207158A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2002 | EP1207157A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2002 | EP1207156A1 Substituted benzylthiazolidine-2,4-dione derivatives |
| 05/22/2002 | EP1207155A1 Drug compositions exhibiting thrombopoietin agonism |
| 05/22/2002 | EP1206472A1 Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent |
| 05/22/2002 | EP1206457A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 05/22/2002 | EP1206447A1 Selective inhibitors of the urokinase plasminogene activators |
| 05/22/2002 | EP0769008B1 Pyrazole derivatives as herbicides |
| 05/22/2002 | EP0766676B1 Compounds for inhibiting phosphodiesterase iv |
| 05/22/2002 | EP0712395B1 Process for the preparation of fluoroalkenylthio heterocyclic derivatives |
| 05/22/2002 | EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 05/22/2002 | CN1350526A A process for the preparation of thiazolidine derivatives |
| 05/21/2002 | US6392055 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A |
| 05/21/2002 | US6392054 Organoleptic |
| 05/21/2002 | US6392046 Aids therapy |
| 05/21/2002 | US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide |
| 05/21/2002 | US6391899 Stroke therapy; cardiovascular disorders |
| 05/21/2002 | US6391894 Myt1 kinase inhibitors |
| 05/21/2002 | US6391878 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 05/16/2002 | WO2002038554A1 Amide derivatives |
| 05/16/2002 | WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/16/2002 | WO2001074793A3 Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 |
| 05/16/2002 | US20020058818 Reacting acid salt of a 2-aminothiazole compound with inorganic acid |
| 05/16/2002 | US20020058817 For cancer therapy |
| 05/16/2002 | US20020058811 Naphthalene derivatives |
| 05/16/2002 | US20020058810 As antiinflammatory agents |
| 05/16/2002 | US20020058666 2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands |
| 05/16/2002 | US20020058658 For use in therapy and prophylaxis of diabetes and obesity |
| 05/16/2002 | US20020058301 Compound for use in the diagnosis and treatment of urogential and kidney disorders |
| 05/16/2002 | US20020056827 Piezoelectric element and process for production thereof |
| 05/16/2002 | DE10055093A1 Cyaninfarbstoff Cyanine dye |
| 05/16/2002 | DE10042786A1 N-Heteroarylmethyl-p-phenylendiamin-Derivate sowie diese Verbindungen enthaltende Oxidationshaarfärbemittel N-Heteroarylmethyl-p-phenylenediamine derivatives containing these compounds as well as oxidation hair |
| 05/15/2002 | EP1205480A2 Tetrakis fluoroalkylborate salts and their use as electrolyte salts |
| 05/15/2002 | EP1205472A1 Process for the preparation of dithiazolyldisulfides |
| 05/15/2002 | EP1204650A1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204643A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 05/15/2002 | EP0729460B1 Substituted 5-ring heterocycles, their preparation and their use |
| 05/15/2002 | CN1349519A Glucokinase activators |
| 05/15/2002 | CN1349511A Benzimidazolrone and analogues, and the use as ligand of progesterone |
| 05/15/2002 | CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1349411A Compositions containing benzimidazolones and progestogens |
| 05/15/2002 | CN1349404A Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis treatment of obesity |
| 05/15/2002 | CN1084746C 1,2,3-benzothiadiazole derivatives |
| 05/15/2002 | CN1084739C 用于制备2－羟基苯甲酰胺衍生物的方法 The method of preparation of 2-hydroxybenzamide derivative for |
| 05/15/2002 | CN1084738C 1,3-di-substituted 2-nitroguanidines prepn. method |
| 05/15/2002 | CN1084737C Substituted sulphonyl amino (thio) caronyl compounds and their use as herbicides |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/15/2002 | CN1084619C Process for preparing medicine composition |
| 05/14/2002 | US6388096 Process for preparation of 2-aminothiazolecarboxamide derivatives |
| 05/14/2002 | US6388088 Antidiabetic agents |
| 05/14/2002 | US6388071 Alkynyl phenyl heteroaromatic glucokinase activators |
| 05/14/2002 | US6388022 Polystyrene |
| 05/14/2002 | US6387935 Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | CA2267186C Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 05/14/2002 | CA2202030C Method for reducing unwanted cellular adhesions |
| 05/10/2002 | WO2002036580A2 Benzoxazole lpaat- beta inhibitors and uses thereof |
| 05/10/2002 | WO2002036561A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/10/2002 | WO2002036550A1 Organic compound having cyano group and insecticides/miticides |
| 05/10/2002 | WO2001064650A3 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 05/10/2002 | CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/10/2002 | CA2363416A1 Tetrakisfluoroalkylborate salts and their use as conducting salts |
| 05/09/2002 | US20020055640 Process for the production of dithiazolyl disulfides |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |